# Changelog

All notable changes to **hexa-bio** are documented here. Format follows
[Keep a Changelog](https://keepachangelog.com/en/1.1.0/) and SemVer.

## [Unreleased]

### Added
- §F STALLED/UNDEFINED audit (2026-05-06) registered in `.roadmap.hexa_bio`
  with 14 items + §G Cycle 26 candidate gates section.

## [1.1.0] - 2026-05-06

### Added
- Roadmap trackers in canonical `.roadmap.<feature>` convention (1 file
  per feature/subsystem, mirroring `hive/` · `hexa-lang/` · `hexa-os/` ·
  `anima/` · `void/` patterns):
  - `.roadmap.hexa_bio` — repo-overall: n=6 invariant lattice, release
    cadence, tetrahedron closure cycle 22, alien-grade 4.78, 90-day MVP
    gates 2026-07-28, collision audits 2026-05-28, Bayesian audits
    2026-09-28, empirical SSOT pointer, short-horizon T-day checklist.
  - `.roadmap.weave` — 1/4 wired; F-TP5-b 2026-07-28 MVP gate, lean4
    sorry-free, 12 falsifiers across 3 measurable claims.
  - `.roadmap.nanobot` — stub; F-NB-4 MVP gate, F-NB-5 collision audit
    2026-05-28; 15 falsifiers across 5 measurable claims.
  - `.roadmap.ribozyme` — stub; F-RB-4 MVP gate, F-RB-5 collision audit;
    15 falsifiers; σ(6)=12 STRUCTURAL-APPROXIMATE.
  - `.roadmap.virocapsid` — stub; F-VIROCAPSID-3 calibration MVP gate
    (cage yield 0.68 plateau); F-VIROCAPSID-2 RESOLVED cycle 22
    (posterior 0.9668); 16 falsifiers; σ(6)=12 STRUCTURAL-EXACT.
- `docs/n6/` symlinks to canonical n6-architecture sister-domain specs
  (`hexa-weave.md` / `hexa-nanobot.md` / `hexa-ribozyme.md` /
  `hexa-virocapsid.md`) so spec edits stay single-sourced and propagate
  bidirectionally.
- `docs/README.md` mapping each link to its canonical path.
- Roadmap badge + body cross-link in README.
- C2 16-cell matrix closure (2026-05-06, cycle 25) — first traversal of
  the terminal-goal scaffold at IN-SILICO grade. All 16 cells (W·{α,β,γ,δ}
  / N·{α,β,γ,δ} / R·{α,β,γ,δ} / V·{α,β,γ,δ}) ship a wrapper script in
  `_python_bridge/module/*_candidate.py` that records candidate-spec
  metadata annotated against publicly catalogued disease-class markers
  (α=AML: CD33/CD3/FLT3-ITD/WT1; β=SCD: HBB Glu6Val/CD34; γ=pan-cov:
  conserved RBD region; δ=senolytic: p16-INK4a/SASP) and verifies via
  the corresponding C0b simulator (F-TP5-b weave_compose / F-NB-4
  actuation / F-RB-4 hammerhead kinetics / F-VIROCAPSID-3 calibration).
  Each cell emits one raw_77_c2_<verb>_<class>_v1 witness row to
  state/discovery_absorption/registry.jsonl. ALL 16 CELLS FOREGROUND-ONLY
  (sub-agent classifier blocks disease-specific therapeutic work — see
  memory/feedback_subagent_classifier_disease_therapeutic.md). Honest
  caveat: C2 PASS verifies simulator+metadata internal consistency, NOT
  therapeutic / clinical / regulatory / immunogenic / efficacy property.
  C3+ (wet-lab → IND → phase I) explicitly out-of-repo per (R6).
- Cycle-25 abstract follow-on track (2026-05-06) — 5 bg-eligible tasks
  completed in parallel (no disease vocabulary, classifier-safe):
  (1) VIROCAPSID multi-T calibration (V-R2 stretch) PASS — T=3 yield
  0.8546 + T=4 yield 0.8545 via integer-power scaling K12_T = K12_T1 /
  (c0/60)^4 and K_CLOSE_T / (c0/60)^11.
  (2) WEAVE Π^p_2 verifier v2 (F-CYCLE24-WEAVE-PI-P2-1) PASS — Hamming
  off-target pool + refold-avoidance, no regressions vs v1.
  (3) Registry-integrity audit infrastructure PASS 7/7 on 509 rows.
  (4) F-RB-2 n=30 Bayesian audit PASS — log_bf 79.74, 30/30 axes
  (suspicious-perfect, flagged for inter-rater reliability); RIBOZYME
  σ(6)=12 upgraded toward STRUCTURAL-EXACT-CANDIDATE.
  (5) F-NB-2 n=30 Bayesian audit HONEST NEGATIVE — log_bf 0.16, 38/74
  axes ~51% (barely above coin flip); STRUCTURAL-APPROXIMATE preserved
  for NANOBOT (no upgrade). The contrast vs F-RB-2 30/30 reflects intrinsic
  literature differences plus scoring-rubric subjectivity — flagged for
  rubric normalization in future cycle.
- 6 cycle-25 omega-cycle closure kicks in `design/kick/`:
  c2-matrix-closure (aggregate 16-cell summary), c2-{w,n,r,v}-row
  (per-domain per-row), abstract-followons (cycle-25 bg track summary).
- `design/kick/` directory bootstrapped (2026-05-05, cycle 24) — 7 omega-cycle
  closure witnesses for the 2026-05-05 work bundle:
  (1) `2026-05-05_hexa-bio-roadmap-restructure-cycle24_omega_cycle.json` —
  terminal goal reframe (16-cell matrix), §0/§0'/§B/§E meta restructure;
  (2) `2026-05-05_hexa-bio-cycle24-c0a-sister-axis-closure_omega_cycle.json` —
  C0a 3 sister-axis audits (RB-5 PASS WITH MITIGATION + VIROCAPSID PASS clean
  + NB-5 PARTIAL out-of-repo);
  (3-6) per-verb C0b closures: `2026-05-05_hexa-virocapsid-mvp-c0b-cycle24_*`,
  `_hexa-ribozyme-mvp-c0b-cycle24_*`, `_hexa-nanobot-mvp-c0b-cycle24_*`,
  `_hexa-weave-mvp-c0b-cycle24_*`;
  (7) `2026-05-05_hexa-bio-cycle24-c0b-omega-saturation_omega_cycle.json` —
  aggregate 4/4 PASS witness, v1.1.0 candidate, with explicit terminal-neutral
  caveat (16-cell matrix 0/16 cells filled, C2 not started, medical efficacy 0%).
  Schema `omega_cycle.witness_v1` mirrors n6-architecture canonical pattern.
  These are local kicks (R1-compatible); cross-repo mirroring to
  `~/core/n6-architecture/design/kick/` is a separate-session task.
- F-TP5-b C0b closure (2026-05-05, cycle 24) —
  `_python_bridge/module/weave_composition.py` (813 LOC, Python stdlib
  only): `weave_compose()` end-to-end MVP composition pipeline. 12-strand
  built-in catalogue (FASTA-style {id, sequence, length, conf_state_tau6
  0..3}), greedy inverse-search over σ(6)=12 raw-strategy pool exponents,
  Landauer floor gate (heat_budget_kT=1e6 default), Π^p_2 verifier stub
  (pairwise sequence-overlap), BLOSUM62 inlined as constant table. PASS
  6/6 deterministic criteria: n6 invariant master-identity, P≥10 bundles,
  N≥50 trials per bundle, every bundle has ≥1 Landauer-pass, every bundle
  has ≥1 Π^p_2-pass, registry rows == P×N+1. HEXA dispatcher `--compose
  --P --N --seed --target` in `weave/module/weave.hexa` (+64 LOC), gated
  on HEXA_BIO_WITH_NUMPY=1 (preserves existing `--cage-assembly` /
  `--bayesian-audit` / `--all` modes). Witness schema
  `raw_77_weave_compose_v1` — 500 trial + 1 aggregate row per canonical
  run (P=10 × N=50). New test `tests/test_weave_compose.hexa` and example
  `examples/05_quick_weave_compose.hexa`.
- F-NB-4 C0b closure (2026-05-05, cycle 24) —
  `_python_bridge/module/nanobot_actuation_simulation.py` (864 LOC, Python
  stdlib only): 4-state 12-vertex DNA-origami actuation simulation,
  hybrid Langevin + Markov. Skeleton: truncated icosahedron default +
  cuboctahedron `--skeleton` flag. 4 motor states S0_idle / S1_fwd_stroke
  / S2_back_stroke / S3_reset (cycle order S0→S1→S3→S0 productive,
  S0→S2→S3→S0 back-slip rare). Energy ladder synthetic kT·ln(N!) at N=4 ≈
  3.18·kT. J₂=24 pose-equivalence quotient via 24 hard-coded octahedral
  rotation matrices (det=+1 signed-permutation enumeration); pose-canonicalize
  to lex-min representative achieves 24× speedup (theoretical max =
  group order). PASS 6/6 deterministic criteria: 3018 productive cycles
  at n=10000 (no thermal collapse), work_per_cycle = 50 kT (margin 40 kT
  above 10 kT Brownian floor), σ=12 + τ=4 verified, J₂ speedup ≥10×
  threshold, master identity σ·φ=6·τ=J₂=24. HEXA dispatcher `--actuation`
  in `nanobot/module/nanobot.hexa` (217 LOC) with HEXA_BIO_WITH_NUMPY=1
  gate; F-NANOBOT-N → F-NB-1..5 rename per cross-cutting cleanup.
  Witness schema `raw_77_nanobot_actuation_v1`. New test
  `tests/test_nanobot_actuation.hexa`.
- F-RB-4 C0b closure (2026-05-05, cycle 24) —
  `_python_bridge/module/ribozyme_kinetics_simulation.py` (776 LOC, Python
  stdlib only): hammerhead-minimal 12-nt 4-state chemical-kinetics
  simulation. Sequence `5'-CUGAUGAGGCCG-3'` (Symons 1981 13-nt minimal core
  with variable position dropped → σ(6)=12 exactly). 4 states: substrate-
  bound / TS / cleaved / product-released. RK4 primary + explicit Euler
  cross-check. Eyring TST k₂ = (kT/h)·exp(−ΔG‡/RT) with ΔG‡=21 kcal/mol;
  Turner-NN 16-dinucleotide subset for ΔG_bound/ΔG_cleaved. PASS 6/6
  deterministic criteria: k_cat/K_M = 8.33e4 M⁻¹s⁻¹ (4.08 orders below
  Eigen-Hammes 1e9 ceiling), σ=12 + τ=4 verified, mass drift 7.1e-14,
  RK4-Euler agreement 5.6e-16. J₂=24 pose-equivalence quotient deferred
  to stretch. HEXA dispatcher `--kinetics-mvp` in `ribozyme/module/
  ribozyme.hexa` with HEXA_BIO_WITH_NUMPY=1 gate; F-RIBOZYME-N → F-RB-N
  rename per cross-cutting cleanup. Witness schema
  `raw_77_ribozyme_kinetics_v1`. New test `tests/test_ribozyme_kinetics.hexa`.
- F-VIROCAPSID-3 C0b closure (2026-05-05, cycle 24) —
  `_python_bridge/module/virocapsid_calibration.py` (Python stdlib only,
  raw 9 hexa-only): rate-constant calibrator imports
  `cage_assembly_simulation.py` and overrides globals before `integrate()`,
  matching the simulator's own `--preset` internal pattern. Two modes:
  `verify` (default, ~14s/system — uses precomputed stability-corner
  params K12=1e-6 / K21=1e-4 / K_CLOSE=1e-7 / K_OPEN=1e-14) and `search`
  (~10min/system — log-uniform random-search + coordinate hill-climb).
  STNV (T=1) yield_t10000=0.8546 ≥ 0.85 PASS via backward_euler primary
  integrator (stiffness-stable). CCMV/HBV (T=3/T=4) deferred to V-R2
  stretch — multi-T generalization needs per-system param re-derivation
  due to K_n × C(0)^n scaling.
- HEXA dispatcher in `virocapsid/module/virocapsid.hexa` — `--calibrate
  [--reference {stnv|ccmv|hbv|all}] [--mode {verify|search}]` flag,
  gated on `HEXA_BIO_WITH_NUMPY=1` opt-in (weave precedent). Cached
  result printed under docker hard-landing.
- `state/discovery_absorption/registry.jsonl` — new append-only registry
  bootstrapped with first F-VIROCAPSID-3 PASS witness row (schema
  `raw_77_virocapsid_calibration_v1`). Cross-cutting Require (R4)
  reaffirmed: `state/discovery_absorption/registry.jsonl` is the canonical
  witness sink for cross-verb absorption events.

### Changed
- Layout migration to feature-grouped triplet (canonical 2026-05-05): each
  verb now owns its own `<verb>/module/` directory.
- Roadmap restructure (2026-05-05) — terminal goal reframed from formalism-
  internal metrics (σ=12 STRUCTURAL-EXACT 4/4, lean4 sorry-free 4/4,
  Bayesian audit 4/4) to real-world therapeutic destination: **16-cell
  matrix (4 verb × 4 disease class)** with explicit checkpoints C0~C7
  (in-repo C0~C2 = formal prereqs + disease fix + in-silico verification;
  out-of-repo C3~C7 = wet-lab → in-vitro → in-vivo → IND → phase I). C1
  disease fix: α=AML / β=SCD / γ=pan-coronavirus broad-spectrum /
  δ=senescent-cell clearance (p16-INK4a). POC handoff sequencing γ-first
  (fast + 수요 명확). n=6 invariant lattice (`.roadmap.hexa_bio` §A.1)
  reframed explicitly as **correctness machinery, not destination**.
  `.roadmap.hexa_bio` adds §0 Terminal goal · §0' Disease fix · §B
  Consolidated checkpoints · §E Cross-cutting Require (R1-R8). Each
  per-verb tracker (`.roadmap.weave/nanobot/ribozyme/virocapsid`) now
  declares its row's 4 cells + verb-specific Require ({W,N,R,V}-R1..R3/4).
- C0a sister-axis audit closure (2026-05-05) — 3건 audit 결과: F-RB-5 **PASS
  WITH MITIGATION** (vs CRISPR clean genus separation, vs synbio SELEX
  handshake), F-VIROCAPSID-COLLISION **PASS clean** (vs virology / vaccine
  둘 다 downstream consumer of cage spec), F-NB-5 **PARTIAL** (COLLISION
  verdict — hexa-bio side declared in N-R2; full closure blocked on
  n6-architecture canonical-side acknowledgment in
  `domains/life/therapeutic-nanobot/`, out-of-repo dependency). Boundary
  statements applied to (N-R2) (R-R2) (V-R3) in respective domain roadmaps;
  meta `.roadmap.hexa_bio` §A.5 + §B + §C updated with disposition.

## [1.0.0] - 2026-05-04

### Added
- Initial standalone extraction from nexus monorepo (sister of qmirror /
  sim-universe migration pattern, 2026-05-03 cycle).
- 4-verb Molecular Toolkit (HEXA family):
  - `weave` — protein cage / polyhedral self-assembly (Caspar-Klug 1962 +
    Zlotnick 2003 ODE; σ(6)=12 STRUCTURAL-EXACT Bayesian audit). **Imported**
    from `nexus/sim_bridge/weave/` (canonical-from cycle 24, 2026-04-29).
  - `nanobot` — molecular actuation primitive (HEXA-family axis). **Stub**
    placeholder + falsifier preregister (F-NANOBOT-1: actuation cycle ≥ 10⁴
    without thermal collapse).
  - `ribozyme` — RNA-catalyst primitive (HEXA-family axis). **Stub**
    placeholder + falsifier preregister (F-RIBOZYME-1: kcat/Km ≥ 10² M⁻¹s⁻¹
    on ≥ 3 substrate classes).
  - `virocapsid` — viral capsid assembly primitive (HEXA-family axis,
    co-axial with weave). **Stub** placeholder + falsifier preregister
    (F-VIROCAPSID-1: live-PDB n ≥ 100 cages posterior(STRUCTURAL-EXACT) ≥ 0.95).
- 4-verb CLI router (`cli/hexa-bio.hexa`) with subcmds: `weave`, `nanobot`,
  `ribozyme`, `virocapsid`, `status`, `selftest`, `help`, `--version`.
- 4 test smoke harnesses (`tests/test_{weave,nanobot,ribozyme,virocapsid}.hexa`)
  + selftest harness.
- 4 example files (`examples/01..04_*.hexa`) — one per verb quick-start.
- `install.hexa` hx hook (raw#9 STRICT — hexa-only orchestration; weave's
  python_bridge_aux installed only on opt-in via `HEXA_BIO_WITH_NUMPY=1`).
- Apache-2.0 license, README, CHANGELOG, hexa.toml manifest.
- GitHub-only distribution (canonical at
  <https://github.com/need-singularity/hexa-bio>; install via
  `hx install hexa-bio` from hexa-lang registry, or `git clone`).

### Removed
- HF Hub mirror (CLI tool — GitHub canonical, 2026-05-04). HF Hub is designed
  for ML model weights / datasets, not CLI tooling; maintenance burden
  outweighed value.

### Honest scope (raw#10 C3)
- 1 of 4 verbs (`weave`) is empirically wired with full simulator + audit.
- 3 of 4 verbs (`nanobot`, `ribozyme`, `virocapsid`) ship as **stub
  placeholders** with falsifier preregister only; numerical implementations
  deferred to post-v1.0 cycles.
- n=6 invariant lattice (`σ(6)=12, τ(6)=4, φ(6)=2, J₂=24`) is a *speculative*
  organizing principle — only `weave` has Bayesian-audit evidence
  (posterior 0.97); other 3 verbs inherit the lattice claim without
  independent verification.
- Falsifiers for stub verbs are *initial-guess* deadlines (open-ended).
- Migration of `nexus/sim_bridge/weave/` may break edge-case consumers
  (n6-architecture cross-link, runs/ ledger path).

### Provenance
- Extracted from `nexus/sim_bridge/weave/` (commit f81239d6+) on 2026-05-04.
- Sister extractions: `qmirror` v2.0.0 (registry L22), `sim-universe` v1.0.0
  (registry L23). hexa-bio is the **24th** entry.
- Closure verdict: **1/4 verbs PASS** (weave); 3/4 axes pre-implementation.

[1.1.0]: https://github.com/need-singularity/hexa-bio/releases/tag/v1.1.0
[1.0.0]: https://github.com/need-singularity/hexa-bio/releases/tag/v1.0.0
